HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ewa Sierko Selected Research

Factor X (Stuart Factor)

5/2019Co-localization of Coagulation Factor X and its Inhibitory System, PZ/ZPI, in Human Endometrial Cancer Tissue.
5/2014Protein Z/protein Z-dependent protease inhibitor system in loco in human gastric cancer.
4/2012Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.
4/2012Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ewa Sierko Research Topics

Disease

36Neoplasms (Cancer)
06/2022 - 06/2003
8Neoplasm Metastasis (Metastasis)
03/2019 - 02/2004
5Breast Neoplasms (Breast Cancer)
05/2016 - 01/2010
5Colonic Neoplasms (Colon Cancer)
04/2012 - 07/2003
4Head and Neck Neoplasms (Head and Neck Cancer)
02/2020 - 01/2017
3Lung Neoplasms (Lung Cancer)
01/2022 - 09/2017
3Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 03/2010
3Thrombosis (Thrombus)
03/2020 - 08/2015
3Pain (Aches)
03/2019 - 10/2015
3Hemorrhage
01/2017 - 12/2003
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 09/2019
2Carcinogenesis
11/2021 - 01/2019
2Carcinoma (Carcinomatosis)
09/2019 - 06/2003
2Endometrial Neoplasms (Endometrial Cancer)
05/2019 - 07/2003
2Anemia
11/2015 - 04/2009
2Stomach Neoplasms (Stomach Cancer)
05/2014 - 06/2003
2Thrombocytosis (Thrombocythemia)
10/2007 - 02/2004
1Hypoxia (Hypoxemia)
01/2022
1Adenocarcinoma
01/2022
1Mucositis
11/2021
1Stomatitis
11/2021
1Chronic Obstructive Pulmonary Disease (COPD)
07/2021
1Cancer Pain
03/2019
1Inflammation (Inflammations)
01/2019
1Dyspnea (Shortness of Breath)
02/2018
1Cachexia
02/2018
1Edema (Dropsy)
02/2018
1Pulmonary Embolism
01/2017
1Lymphoma (Lymphomas)
10/2016
1Oxyphilic Adenoma (Oncocytoma)
10/2016

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2003
10Hemostatics (Antihemorrhagics)IBA
05/2019 - 06/2003
10Thromboplastin (Tissue Factor)IBA
05/2016 - 06/2003
6FibrinIBA
06/2016 - 06/2003
6plasma protein Z (protein Z)IBA
05/2014 - 12/2003
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 06/2003
5ThrombinFDA Link
10/2020 - 06/2003
5lipoprotein-associated coagulation inhibitor (TFPI)IBA
01/2010 - 06/2003
4Blood Coagulation Factors (Coagulation Factor)IBA
05/2019 - 02/2005
4Factor X (Stuart Factor)IBA
05/2019 - 04/2012
4Protease Inhibitors (Protease Inhibitor)IBA
05/2014 - 07/2010
4AnticoagulantsIBA
05/2014 - 02/2004
4Messenger RNA (mRNA)IBA
05/2014 - 10/2007
4Fibrinogen (Factor I)FDA Link
04/2012 - 06/2003
3Biological ProductsIBA
11/2021 - 04/2006
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2017 - 02/2004
3Proteinase-Activated ReceptorsIBA
07/2016 - 12/2015
3Prothrombin (Factor II)IBA
05/2014 - 06/2003
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
07/2003 - 06/2003
3Tissue Plasminogen Activator (Alteplase)FDA Link
07/2003 - 06/2003
2Analgesics (Analgesic Drugs)IBA
03/2019 - 10/2015
2Peptide Hydrolases (Proteases)FDA Link
01/2019 - 02/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2016 - 05/2016
2EnzymesIBA
06/2016 - 08/2015
2Protein SIBA
03/2010 - 06/2003
2Protein CIBA
03/2010 - 06/2003
2tissue-factor-pathway inhibitor 2 (PP5)IBA
10/2007 - 07/2003
2Thrombopoietin (c-mpl Ligand)IBA
10/2007 - 02/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2007 - 02/2004
2von Willebrand FactorIBA
12/2003 - 06/2003
2Plasminogen InactivatorsIBA
07/2003 - 06/2003
2PlasminogenIBA
07/2003 - 06/2003
2Plasminogen Activators (Plasminogen Activator)IBA
06/2003 - 06/2003
1Thyroid HormonesIBA
01/2022
1CytokinesIBA
11/2021
1Glycerophospholipids (Phosphoglycerides)IBA
07/2021
1SphingomyelinsIBA
07/2021
1AntithrombinsIBA
10/2020
1AntibodiesIBA
05/2019
1StrontiumIBA
03/2019
1Diphosphonates (Bisphosphonates)IBA
03/2019
1RadiumIBA
03/2019
1Radioisotopes (Radionuclides)IBA
03/2019
1Endothelial Protein C ReceptorIBA
01/2019
1PAR-1 ReceptorIBA
01/2019
1HaptoglobinsIBA
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1GelsIBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1AlbuminsIBA
01/2019
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2019
1Transferrin (beta 2 Transferrin)IBA
01/2019
1ClusterinIBA
01/2019
1MegestrolIBA
02/2018
1Pharmaceutical PreparationsIBA
02/2018
1NexusIBA
01/2017
1Prednisone (Sone)FDA LinkGeneric
10/2016
1Rituximab (Mabthera)FDA Link
10/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2016

Therapy/Procedure

9Drug Therapy (Chemotherapy)
06/2022 - 07/2011
9Therapeutics
11/2021 - 02/2004
7Radiotherapy
01/2022 - 10/2015
5Chemoradiotherapy
03/2019 - 10/2015
2Hospice Care (Care, Bereavement)
03/2020 - 02/2018
2Perioperative Period
03/2020 - 02/2018
1Terminal Care (Care, Terminal)
03/2020
1Brachytherapy
03/2019
1Precision Medicine
09/2017
1Nephrectomy
10/2016